Chemotherapy can cause degeneration of peripheral sensory and motor nerves and cause patients to present with sensory disturbances, balance problems or weakness. The symptoms …

Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting side effect experienced by patients receiving treatment for cancer. Approximately 30–40% of patients …

2024年9月23日 · Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect of cancer therapy that can have a profound impact on quality of life and survivorship . …

2022年8月23日 · Peripheral neuropathy — a nerve disorder that can cause weakness, numbness, pain, and tingling or a “pins and needles” feeling — is a common side effect of chemotherapy …

Some of the most common causes of peripheral neuropathy are medicines used to treat cancer. When this happens, it is called chemotherapy-induced peripheral neuropathy (CIPN). The risk …

2020年7月14日 · Chemotherapy-induced neuropathy is a serious clinical problem caused by a substantial number of cytotoxic drugs, including taxanes, platinums, vinca alkaloids, …

Chemotherapy and other drugs used to treat cancer can cause peripheral neuropathy. This is termed chemotherapy-induced peripheral neuropathy (or CIPN). What Increases the Risk of …

Chemotherapy-induced peripheral neuropathy (CIPN) is a nerve-damaging side effect of antineoplastic agents in the common cancer treatment, chemotherapy. [1] CIPN afflicts …

Chemotherapy-induced peripheral neuropathy (CIPN) is a common toxicity associated with treatment with platinum-based agents, taxanes, vinca alkaloids, and other specific agents.

Chemotherapy-induced neuropathy is a serious clin-ical problem caused by a substantial number of cy-totoxic drugs, including taxanes, platinums, vinca alkaloids, epothilones, eribulin, and …